Lung cancer rapid screening test PANAMutyper™

EML4-ALK fusion geneFFPE tissues

PANAMutyper™ EML4-ALK Screening Kit is the qualitative diagnostic test kit which is able to detect 16 different EML4-ALK fusion genes of tissue from non-small cell lung cancer (NSCLC) patients using peptide nucleic acid (PNA) probes in a real-time PCR system. The PANAMutyper™ EML4-ALK Screening Kit is intended as an aid for screening EML4-ALK fusion-positive NSCLC patients who would be sensitive for receiving ALK inhibitor therapy such as crizotinib. DETAILS The PANAMutyper™ EML4-ALK Screening Kit is an in vitro diagnostic reagent for detecting 16 different EML4-ALK fusion genes of formalin-fixed paraffin-embedded (FFPE) tissue fresh, tissues and biopsy tissues from non-small cell lung cancer (NSCLC) patients. FEATURES - 01 One-step RT-PCR technology 02 Detection of 16 EML4-ALK fusion gene variants in one tube reaction 03 High sensitivity, specificity and reproducibility 04 Short running time 05 Simple workflow 06 Easy result reading by automatic analyzing program PROCEDURE Total RNA extraction Sample preperation RT-PCR(real-time) Analysis of result COMPATIBLE SAMPE TYPE - Formalin-fixed paraffin-embedded(FFPE) tissue - Fresh tissue and biopsy sample